Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HB-adMSCs vs Placebo in Crohn's Disease
NCT07077746Phase 2Recruiting
- Sponsor
- Hope Biosciences
- Start
- Jul 2026
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic HB-adMSCs in Crohn's disease, sponsored by Hope Biosciences. Started Jul 2026; status: recruiting.
02
Drugs
allogeneic HB-adMSCs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07077746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07077746.